I wouldn't go as far as to rule out a CR prior to results but i lean towards them waiting for INV102 results. It would be poor capital mgmt to raise now at a lower price if you suspected strong, price moving results in the near term.
I'm just wondering, why release an August presentation now and not release a fresh preso that accompanies the results on the trial? Is it to promote the company hecause there is actually an imminent CR or isit just to build-up some hype, leading into results? I guess all will be revealed in the next 7 weeks.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
9.7¢ |
Change
0.003(3.19%) |
Mkt cap ! $8.232M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.7¢ | $3.425K | 34.93K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5200 | 9.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 244080 | 3 |
View Market Depth
| Last trade - 15.55pm 25/07/2025 (20 minute delay) ? |
| IVX (ASX) Chart |